LivaNova launches Bi-Flow to prevent limb ischemia during cardiac surgery.
LivaNova PLC launched its innovative arterial femoral cannula, Bi-Flow, designed to prevent limb ischemia during cardiac surgery. LivaNova Bi-Flow received CE Mark earlier this year and is the only bidirectional arterial cannula designed to prevent leg ischemia during cardiac surgery procedures requiring femoral artery cannulation.
In a clinical study, Bi-Flow was easily inserted and removed without complications and was proven to provide simultaneous systemic and distal perfusion of the limb in a safe and reproducible way.
Bi-Flow is now available in Europe, Canada and other select countries in one size (19 fr), and is currently in pre-market notification for the U.S. The line will expand next year with more sizes and a version validated for Extracorporeal Life Support to address long-term procedures.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins